206 related articles for article (PubMed ID: 8521296)
21. Thalidomide inhibits the replication of human immunodeficiency virus type 1.
Makonkawkeyoon S; Limson-Pobre RN; Moreira AL; Schauf V; Kaplan G
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5974-8. PubMed ID: 8327469
[TBL] [Abstract][Full Text] [Related]
22. In vitro levels of cytokines in response to purified protein derivative (PPD) antigen in a population with high prevalence of pulmonary tuberculosis.
Giampietro F; de Waard JH; Rivas-Santiago B; Enciso-Moreno JA; Salgado A; Araujo Z
Hum Immunol; 2010 Nov; 71(11):1099-104. PubMed ID: 20650294
[TBL] [Abstract][Full Text] [Related]
23. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.
Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G
J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139
[TBL] [Abstract][Full Text] [Related]
24. Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa.
Winkler S; Necek M; Winkler H; Adegnika AA; Perkmann T; Ramharter M; Kremsner PG
Microbes Infect; 2005 Jul; 7(9-10):1161-9. PubMed ID: 15908253
[TBL] [Abstract][Full Text] [Related]
25. A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis.
Austin AS; Mahida YR; Clarke D; Ryder SD; Freeman JG
Aliment Pharmacol Ther; 2004 Jan; 19(1):79-88. PubMed ID: 14687169
[TBL] [Abstract][Full Text] [Related]
26. Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease.
Kawai T; Watanabe N; Yokoyama M; Arai K; Oana S; Harayama S; Yasui K; Oh-Ishi T; Onodera M
Clin Immunol; 2013 May; 147(2):122-8. PubMed ID: 23583898
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha increased production during thalidomide treatment in patients with tuberculosis and human immunodeficiency virus coinfection.
Gori A; Rossi MC; Trabattoni D; Marchetti G; Fusi ML; Molteni C; Clerici M; Franzetti1 F
J Infect Dis; 2000 Aug; 182(2):639-40. PubMed ID: 10915104
[No Abstract] [Full Text] [Related]
28. Experimental murine mycobacteriosis: evaluation of the functional activity of alveolar macrophages in thalidomide- treated mice.
Arruda MS; Richini VB; Oliveira SM; Vilani-Moreno FR
Braz J Med Biol Res; 2004 Apr; 37(4):485-92. PubMed ID: 15064811
[TBL] [Abstract][Full Text] [Related]
29. Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial.
Drenth JP; Vonk AG; Simon A; Powell R; van der Meer JW
J Pharmacol Exp Ther; 2001 Sep; 298(3):1221-6. PubMed ID: 11504824
[TBL] [Abstract][Full Text] [Related]
30. Thalidomide and HIV: several possible uses.
Smith D
AIDS Treat News; 1995 Apr; (no 221):1-4. PubMed ID: 11362402
[TBL] [Abstract][Full Text] [Related]
31. Effect of thalidomide in patients with chronic heart failure.
Gullestad L; Semb AG; Holt E; Skårdal R; Ueland T; Yndestad A; Frøland SS; Aukrust P
Am Heart J; 2002 Nov; 144(5):847-50. PubMed ID: 12422154
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alphabetaTCR+ T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra.
Tsukaguchi K; de Lange B; Boom WH
Cell Immunol; 1999 May; 194(1):12-20. PubMed ID: 10357876
[TBL] [Abstract][Full Text] [Related]
33. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
Moreira AL; Sampaio EP; Zmuidzinas A; Frindt P; Smith KA; Kaplan G
J Exp Med; 1993 Jun; 177(6):1675-80. PubMed ID: 8496685
[TBL] [Abstract][Full Text] [Related]
34. The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus.
Haslett P; Hempstead M; Seidman C; Diakun J; Vasquez D; Freedman VH; Kaplan G
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):1047-54. PubMed ID: 9264292
[TBL] [Abstract][Full Text] [Related]
35. An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis.
Huizinga TW; Dijkmans BA; van der Velde EA; van de Pouw Kraan TC; Verweij CL; Breedveld FC
Ann Rheum Dis; 1996 Nov; 55(11):833-6. PubMed ID: 8976641
[TBL] [Abstract][Full Text] [Related]
36. The thalidomide comeback.
HIV Hotline; 1998 May; 8(2):7, 9, 15. PubMed ID: 11365364
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol enhances TNF-α production in human monocytes upon bacterial stimulation.
Gualdoni GA; Kovarik JJ; Hofer J; Dose F; Pignitter M; Doberer D; Steinberger P; Somoza V; Wolzt M; Zlabinger GJ
Biochim Biophys Acta; 2014 Jan; 1840(1):95-105. PubMed ID: 24035785
[TBL] [Abstract][Full Text] [Related]
38. Protective effect of thalidomide on endotoxin-induced liver injury.
Enomoto N; Takei Y; Hirose M; Kitamura T; Ikejima K; Sato N
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):2S-6S. PubMed ID: 12960498
[TBL] [Abstract][Full Text] [Related]
39. Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-α drugs: report of 3 cases and literature review.
Scribano ML; Cantoro L; Marrollo M; Cosintino R; Kohn A
J Clin Gastroenterol; 2014 Jul; 48(6):530-3. PubMed ID: 24667589
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
